134 related articles for article (PubMed ID: 23576494)
1. Cross-sectional and longitudinal associations between insulin-like growth factor I and metabolic syndrome: a general population study in German adults.
Friedrich N; Nauck M; Schipf S; Völzke H; Brabant G; Wallaschofski H
Diabetes Metab Res Rev; 2013 Sep; 29(6):452-62. PubMed ID: 23576494
[TBL] [Abstract][Full Text] [Related]
2. Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP).
Spilcke-Liss E; Friedrich N; Dörr M; Schminke U; Völzke H; Brabant G; Nauck M; Wallaschofski H
Clin Endocrinol (Oxf); 2011 Jul; 75(1):70-5. PubMed ID: 21521279
[TBL] [Abstract][Full Text] [Related]
3. Association between the insulin-like growth factor axis in serum and periodontitis in the Study of Health in Pomerania: an exploratory study.
Harb AN; Holtfreter B; Friedrich N; Wallaschofski H; Nauck M; Albers M; Meisel P; Biffar R; Kocher T
J Clin Periodontol; 2012 Oct; 39(10):931-9. PubMed ID: 22882716
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
Undén AL; Elofsson S; Brismar K
Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
[TBL] [Abstract][Full Text] [Related]
5. IGF-I/IGFBP-3 ratio: a mechanistic insight into the metabolic syndrome.
Sierra-Johnson J; Romero-Corral A; Somers VK; Lopez-Jimenez F; Mälarstig A; Brismar K; Hamsten A; Fisher RM; Hellénius ML
Clin Sci (Lond); 2009 Mar; 116(6):507-12. PubMed ID: 18816247
[TBL] [Abstract][Full Text] [Related]
6. Reference ranges of serum IGF-1 and IGFBP-3 levels in a general adult population: results of the Study of Health in Pomerania (SHIP).
Friedrich N; Alte D; Völzke H; Spilcke-Liss E; Lüdemann J; Lerch MM; Kohlmann T; Nauck M; Wallaschofski H
Growth Horm IGF Res; 2008 Jun; 18(3):228-37. PubMed ID: 17997337
[TBL] [Abstract][Full Text] [Related]
7. The association between insulin-like growth factor I and bone turnover markers in the general adult population.
Niemann I; Hannemann A; Nauck M; Spielhagen C; Völzke H; Wallaschofski H; Friedrich N
Bone; 2013 Sep; 56(1):184-90. PubMed ID: 23792936
[TBL] [Abstract][Full Text] [Related]
8. Insulin-like growth factor binding protein-2 (IGFBP-2) is a marker for the metabolic syndrome.
Heald AH; Kaushal K; Siddals KW; Rudenski AS; Anderson SG; Gibson JM
Exp Clin Endocrinol Diabetes; 2006 Jul; 114(7):371-6. PubMed ID: 16915540
[TBL] [Abstract][Full Text] [Related]
9. Association of IGF-I and the IGF-I/IGFBP-3 ratio with plasma aldosterone levels in the general population.
Hannemann A; Wallaschofski H; Rettig R; Völzke H; Samietz S; Nauck M; Bidlingmaier M; Friedrich N
Horm Metab Res; 2012 Mar; 44(3):228-33. PubMed ID: 22328165
[TBL] [Abstract][Full Text] [Related]
10. A potential inverse association between insulin-like growth factor I and hypertension in a cross-sectional study.
Hunt KJ; Lukanova A; Rinaldi S; Lundin E; Norat T; Palmqvist R; Stattin P; Riboli E; Hallmans G; Kaaks R
Ann Epidemiol; 2006 Jul; 16(7):563-71. PubMed ID: 16431135
[TBL] [Abstract][Full Text] [Related]
11. Insulin-like growth factor I, insulin-like growth factor binding protein 3, and atrial fibrillation in the elderly.
Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Seux ML; Treluyer JM; Epelbaum J; Bouc YL; Hanon O
J Gerontol A Biol Sci Med Sci; 2014 Aug; 69(8):1025-32. PubMed ID: 24368776
[TBL] [Abstract][Full Text] [Related]
12. Association of insulin-like growth factor I and insulin-like growth factor-binding protein-3 with intelligence quotient among 8- to 9-year-old children in the Avon Longitudinal Study of Parents and Children.
Gunnell D; Miller LL; Rogers I; Holly JM;
Pediatrics; 2005 Nov; 116(5):e681-6. PubMed ID: 16263982
[TBL] [Abstract][Full Text] [Related]
13. Low levels of insulin-like growth-factor-binding protein-1 (IGFBP-1) are prospectively associated with the incidence of type 2 diabetes and impaired glucose tolerance (IGT): the Söderåkra Cardiovascular Risk Factor Study.
Petersson U; Ostgren CJ; Brudin L; Brismar K; Nilsson PM
Diabetes Metab; 2009 Jun; 35(3):198-205. PubMed ID: 19297224
[TBL] [Abstract][Full Text] [Related]
14. Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations.
Friedrich N; Haring R; Nauck M; Lüdemann J; Rosskopf D; Spilcke-Liss E; Felix SB; Dörr M; Brabant G; Völzke H; Wallaschofski H
J Clin Endocrinol Metab; 2009 May; 94(5):1732-9. PubMed ID: 19223521
[TBL] [Abstract][Full Text] [Related]
15. Dietary determinants of circulating insulin-like growth factor (IGF)-I and IGF binding proteins 1, -2 and -3 in women in the Netherlands.
Vrieling A; Voskuil DW; Bueno de Mesquita HB; Kaaks R; van Noord PA; Keinan-Boker L; van Gils CH; Peeters PH
Cancer Causes Control; 2004 Oct; 15(8):787-96. PubMed ID: 15456992
[TBL] [Abstract][Full Text] [Related]
16. Bioavailable IGF-1 and its Relation to the Metabolic Syndrome in a Bi-Ethnic Population of Men and Women.
Koegelenberg AS; Schutte R; Smith W; Schutte AE
Horm Metab Res; 2016 Feb; 48(2):130-6. PubMed ID: 26348017
[TBL] [Abstract][Full Text] [Related]
17. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
Ahmed RL; Thomas W; Schmitz KH
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factors and breast cancer risk in Chinese women.
Yu H; Jin F; Shu XO; Li BD; Dai Q; Cheng JR; Berkel HJ; Zheng W
Cancer Epidemiol Biomarkers Prev; 2002 Aug; 11(8):705-12. PubMed ID: 12163322
[TBL] [Abstract][Full Text] [Related]
19. Association of circulating IGF-I and IGFBP-3 concentrations and exercise capacity in healthy volunteers: results of the Study of Health in Pomerania.
Gläser S; Friedrich N; Ewert R; Schäper C; Krebs A; Dörr M; Völzke H; Felix SB; Nauck M; Wallaschofski H; Koch B
Growth Horm IGF Res; 2010 Dec; 20(6):404-10. PubMed ID: 20889360
[TBL] [Abstract][Full Text] [Related]
20. The role of sex hormone-binding globulin and testosterone in the risk of incident metabolic syndrome.
Haring R; Völzke H; Spielhagen C; Nauck M; Wallaschofski H
Eur J Prev Cardiol; 2013 Dec; 20(6):1061-8. PubMed ID: 22711969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
